Norges Bank’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-71,060
Closed -$4.78M 1940
2023
Q4
$4.78M Sell
71,060
-7,913
-10% -$551K ﹤0.01% 1686
2023
Q3
$5.91M Sell
78,973
-17,767
-18% -$1.58M ﹤0.01% 1645
2023
Q2
$8.92M Hold
96,740
﹤0.01% 1576
2023
Q1
$10M Sell
96,740
-8,941
-8% -$991K ﹤0.01% 1580
2022
Q4
$12.2M Hold
105,681
﹤0.01% 1493
2022
Q3
$11.5M Sell
105,681
-3,499
-3% -$501K ﹤0.01% 1478
2022
Q2
$19.7M Sell
109,180
-16,720
-13% -$2.99M 0.01% 1248
2022
Q1
$21.5M Buy
125,900
+14,159
+13% +$2.67M ﹤0.01% 1369
2021
Q4
$23.4M Hold
111,741
﹤0.01% 1394
2021
Q3
$21.5M Buy
111,741
+2,024
+2% +$498K ﹤0.01% 1439
2021
Q2
$31M Sell
109,717
-24,705
-18% -$6.69M 0.01% 1251
2021
Q1
$28.5M Sell
134,422
-15,562
-10% -$3.72M 0.01% 1321
2020
Q4
$29.4M Sell
149,984
-8,554
-5% -$1.51M 0.01% 1327
2020
Q3
$26.1M Sell
158,538
-2,092
-1% -$344K 0.01% 1246
2020
Q2
$22.3M Buy
160,630
+21,672
+16% +$1.99M 0.01% 1366
2020
Q1
$8.69M Hold
138,958
﹤0.01% 1670
2019
Q4
$15.2M Buy
138,958
+28,111
+25% +$2.72M ﹤0.01% 1666
2019
Q3
$11.5M Sell
110,847
-34,775
-24% -$3.74M ﹤0.01% 1727
2019
Q2
$18.7M Buy
145,622
+58,652
+67% +$8.15M 0.01% 1548
2019
Q1
$11.1M Buy
86,970
+5,761
+7% +$731K ﹤0.01% 1766
2018
Q4
$10.2M Buy
81,209
+18,563
+30% +$3.18M ﹤0.01% 1739
2018
Q3
$13.9M Buy
+62,646
New +$12.7M ﹤0.01% 1702
2014
Q4
Sell
-65,104
Closed -$2.14M 2363
2014
Q3
$2.14M Buy
+65,104
New +$2M ﹤0.01% 2089

Other funds holding MED

Norges Bank's MED Position: Q1 2024 in Review

Norges Bank sold out of Medifast (MED) in Q1 2024, closing a stake of 71,060 shares — an estimated $4.78M sold.

Norges Bank first reported a position in MED in Q3 2014 and held it in 23 quarters. The position peaked at $31M in Q2 2021. 186 funds tracked by Wall St. Rank hold MED as of Q1 2024.

  • Norges Bank reported no remaining Medifast position as of Q1 2024 after selling out during the quarter.
  • Norges Bank sold 71,060 Medifast shares in Q1 2024, an estimated $4.78M.
  • Norges Bank first reported a position in Medifast in Q3 2014 and held it in 23 quarters.
  • Norges Bank's Medifast position peaked at $31M in Q2 2021.
  • 186 funds tracked by Wall St. Rank held Medifast as of Q1 2024.

Based on Norges Bank's 13F filing for Q1 2024, filed 14 May 2024.